ARYA Sciences Acquisition Corp. III (ARYA): Price and Financial Metrics


ARYA Sciences Acquisition Corp. III (ARYA)

Today's Latest Price: $11.84 USD

0.34 (2.96%)

Updated Jan 25 6:55pm

Add ARYA to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 260 in Financial Services (Enterprise)

See all "A" rated Strong Buy stocks

ARYA Stock Price Chart Interactive Chart >

Price chart for ARYA

ARYA Price/Volume Stats

Current price $11.84 52-week high $12.60
Prev. close $11.50 52-week low $10.06
Day low $11.50 Volume 63,300
Day high $11.90 Avg. volume 148,567
50-day MA $10.82 Dividend yield N/A
200-day MA $0.00 Market Cap 197.85M

ARYA Sciences Acquisition Corp. III (ARYA) Company Bio


ARYA Sciences Acquisition Corp III intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was founded in 2020 and is based in New York, New York.


ARYA Latest News Stream


Event/Time News Detail
Loading, please wait...

ARYA Latest Social Stream


Loading social stream, please wait...

View Full ARYA Social Stream

Latest ARYA News From Around the Web

Below are the latest news stories about ARYA Sciences Acquisition Corp III that investors may wish to consider to help them evaluate ARYA as an investment opportunity.

Arya Sciences Acquisition Corp. Shareholders Approve Business Combination Transaction with Immatics

Arya Sciences Acquisition Corp. (NASDAQ: ARYA or "Arya"), a special purpose acquisition company sponsored by Perceptive Advisors, and Immatics Biotechnologies GmbH ("Immatics"), a clinical-stage biopharmaceutical company active in the discovery and development of T cell redirecting cancer immunotherapies, today announced that its respective shareholders approved the business combination between Arya and Immatics announced on March 17, 2020. None of Arya’s shareholders redeemed their shares in connection with the ARYA shareholder approval. The respective boards of directors of both Arya and Immatics had previously approved the business combination.

Yahoo | June 29, 2020

ACT NOW: Monteverde & Associates Is Investigating the Merger

NEW YORK, NY / ACCESSWIRE / June 17, 2020 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York ...

Yahoo | June 17, 2020

STOCKHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Arya Sciences Acquisition Corp. - ARYA

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Arya Sciences Acquisition Corp. ("Arya Sciences" or the "Company") (NasdaqGS: ARYA) relating its combination with Immatics B.V., a Netherlands private limited company. Under the terms of the agreement, each outstanding share of Arya common stock, will be automatically exchanged for one share of the newly formed company, Immatics N.V.

Yahoo | June 11, 2020

Read More 'ARYA' Stories Here

ARYA Price Returns

1-mo N/A
3-mo 14.18%
6-mo N/A
1-year 11.93%
3-year N/A
5-year N/A
YTD 9.12%
2020 N/A
2019 0.00%
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8046 seconds.